SG Americas Securities
CALA

SG Americas Securities’s Calithera Biosciences, Inc CALA Stock Holding History

SG Americas Securities’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-650
Closed -$31K – 3383
2021
Q1 		$31K Buy
+650
New +$37.8K ﹤0.01% 3193
2020
Q3 		– Sell
-1,784
Closed -$188K – 3722
2020
Q2 		$188K Buy
1,784
+819
+85% +$97.3K ﹤0.01% 2908
2020
Q1 		$86K Buy
+965
New +$115K ﹤0.01% 3057
2019
Q3 		– Sell
-1,431
Closed -$112K – 3315
2019
Q2 		$112K Buy
+1,431
New +$162K ﹤0.01% 2750
2017
Q2 		– Sell
-914
Closed -$211K – 3629
2017
Q1 		$211K Buy
+914
New +$158K ﹤0.01% 2396

Other funds holding CALA

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DMPV
Delphi Management Partners VIII San Mateo, California $138M AUM 56.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SG Americas Securities's CALA Position: Q2 2021 in Review

SG Americas Securities sold out of Calithera Biosciences, Inc (CALA) in Q2 2021, closing a stake of 650 shares — an estimated $31K sold.

SG Americas Securities first reported a position in CALA in Q1 2017 and held it in 5 quarters. The position peaked at $211K in Q1 2017. 76 funds tracked by Wall St. Rank hold CALA as of Q2 2021.

  • SG Americas Securities reported no remaining Calithera Biosciences, Inc position as of Q2 2021 after selling out during the quarter.
  • SG Americas Securities sold 650 Calithera Biosciences, Inc shares in Q2 2021, an estimated $31K.
  • SG Americas Securities first reported a position in Calithera Biosciences, Inc in Q1 2017 and held it in 5 quarters.
  • SG Americas Securities's Calithera Biosciences, Inc position peaked at $211K in Q1 2017.
  • 76 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q2 2021.

Based on SG Americas Securities's 13F filing for Q2 2021, filed 12 Aug 2021.